| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,218 |
6,300 |
$341K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,248 |
1,729 |
$264K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,710 |
9,341 |
$227K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,582 |
1,397 |
$210K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,609 |
1,985 |
$177K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
16,998 |
14,432 |
$177K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,709 |
1,294 |
$161K |
| G0378 |
Hospital observation service, per hour |
1,552 |
1,239 |
$142K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
27,155 |
19,219 |
$119K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,029 |
11,405 |
$98K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,226 |
1,918 |
$97K |
| 71046 |
Radiologic examination, chest; 2 views |
7,451 |
5,817 |
$97K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,905 |
8,539 |
$94K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
16,950 |
4,978 |
$91K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
26,724 |
21,613 |
$79K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
2,052 |
1,791 |
$65K |
| 80053 |
Comprehensive metabolic panel |
29,929 |
24,315 |
$56K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
709 |
360 |
$50K |
| 73630 |
|
3,354 |
2,238 |
$49K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,397 |
3,132 |
$48K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
11,156 |
3,630 |
$44K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,955 |
4,197 |
$40K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
654 |
535 |
$39K |
| 94762 |
|
996 |
889 |
$38K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,770 |
4,923 |
$37K |
| 11721 |
|
5,907 |
2,991 |
$37K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
1,421 |
1,237 |
$36K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,123 |
4,419 |
$35K |
| 71250 |
|
485 |
369 |
$35K |
| A0425 |
Ground mileage, per statute mile |
4,747 |
3,760 |
$32K |
| 93017 |
|
643 |
594 |
$28K |
| 73562 |
|
1,588 |
1,120 |
$26K |
| 71045 |
Radiologic examination, chest; single view |
2,743 |
1,945 |
$22K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,616 |
2,808 |
$22K |
| 72100 |
|
1,308 |
1,059 |
$21K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,001 |
3,863 |
$20K |
| 73030 |
|
1,364 |
1,049 |
$20K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
356 |
286 |
$18K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
401 |
294 |
$18K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
30,461 |
23,781 |
$18K |
| 84443 |
Thyroid stimulating hormone (TSH) |
11,452 |
10,924 |
$18K |
| J2704 |
Injection, propofol, 10 mg |
3,489 |
3,181 |
$16K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
175 |
132 |
$15K |
| 94760 |
|
2,737 |
2,451 |
$15K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
378 |
345 |
$15K |
| 99215 |
Prolong outpt/office vis |
1,797 |
1,211 |
$13K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,428 |
890 |
$13K |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
1,076 |
968 |
$12K |
| 97161 |
|
1,231 |
1,138 |
$12K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
9,250 |
8,904 |
$12K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
702 |
638 |
$11K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,869 |
1,719 |
$11K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
800 |
592 |
$11K |
| 73610 |
|
1,070 |
764 |
$10K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,677 |
1,237 |
$10K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
481 |
341 |
$9K |
| 96376 |
|
2,197 |
1,286 |
$9K |
| 73130 |
|
767 |
452 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
42,725 |
34,876 |
$8K |
| 84484 |
|
6,671 |
4,918 |
$8K |
| 97162 |
|
703 |
643 |
$8K |
| 80061 |
Lipid panel |
10,329 |
9,929 |
$8K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,935 |
3,806 |
$8K |
| 83735 |
|
11,788 |
9,557 |
$8K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,592 |
929 |
$7K |
| 97035 |
|
2,666 |
966 |
$7K |
| 73502 |
|
395 |
318 |
$6K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,559 |
3,931 |
$6K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,302 |
4,386 |
$5K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
6,514 |
5,953 |
$5K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
9,811 |
8,172 |
$5K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,631 |
1,215 |
$5K |
| 82043 |
|
2,068 |
1,992 |
$5K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
921 |
824 |
$4K |
| 82728 |
|
2,493 |
2,329 |
$4K |
| 83880 |
|
1,555 |
1,325 |
$4K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
403 |
358 |
$3K |
| 82607 |
|
2,451 |
2,353 |
$3K |
| 85027 |
|
3,976 |
3,735 |
$3K |
| 81001 |
|
5,380 |
4,643 |
$3K |
| J2785 |
Injection, regadenoson, 0.1 mg |
113 |
101 |
$3K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
90 |
66 |
$3K |
| 84439 |
|
2,517 |
2,380 |
$3K |
| 87077 |
|
2,638 |
2,387 |
$3K |
| 83550 |
|
2,197 |
2,069 |
$3K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
532 |
500 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,529 |
2,279 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,773 |
3,400 |
$3K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
750 |
333 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
628 |
584 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,141 |
1,081 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,463 |
1,352 |
$3K |
| 86140 |
|
3,209 |
2,790 |
$2K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
176 |
149 |
$2K |
| 76830 |
Ultrasound, transvaginal |
136 |
120 |
$2K |
| 71271 |
|
353 |
245 |
$2K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,770 |
1,616 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
47 |
24 |
$2K |
| 83690 |
|
3,870 |
3,442 |
$2K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
12 |
12 |
$2K |
| 81003 |
|
6,017 |
5,504 |
$2K |
| 93971 |
|
75 |
40 |
$2K |
| 83540 |
|
2,365 |
2,224 |
$2K |
| 93242 |
|
43 |
41 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,929 |
5,225 |
$2K |
| 82570 |
|
815 |
765 |
$2K |
| 87186 |
|
1,521 |
1,416 |
$2K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
373 |
347 |
$1K |
| 85610 |
|
5,062 |
3,172 |
$1K |
| 96367 |
|
321 |
250 |
$1K |
| Q3014 |
Telehealth originating site facility fee |
923 |
825 |
$1K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
444 |
419 |
$1K |
| 82248 |
|
1,350 |
1,214 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,143 |
1,039 |
$1K |
| 83605 |
|
2,198 |
1,875 |
$1K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
13 |
13 |
$1K |
| 85651 |
|
2,268 |
2,068 |
$1K |
| 87040 |
|
1,073 |
919 |
$1K |
| 99442 |
|
84 |
78 |
$1K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
60 |
59 |
$983.43 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,655 |
1,473 |
$975.51 |
| 84153 |
|
243 |
234 |
$947.49 |
| 72141 |
|
13 |
12 |
$944.00 |
| 98929 |
|
110 |
65 |
$889.95 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
130 |
118 |
$874.03 |
| 99443 |
|
44 |
42 |
$873.08 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
2,476 |
2,297 |
$845.00 |
| J1815 |
Injection, insulin, per 5 units |
399 |
240 |
$791.47 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
122 |
41 |
$788.60 |
| 93016 |
|
588 |
551 |
$768.27 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
246 |
219 |
$744.75 |
| 90715 |
|
444 |
426 |
$686.01 |
| 82746 |
|
420 |
400 |
$683.14 |
| 87631 |
|
459 |
442 |
$676.91 |
| 97165 |
|
57 |
50 |
$656.29 |
| 93225 |
|
14 |
14 |
$653.00 |
| 80305 |
|
1,033 |
992 |
$583.82 |
| 93018 |
|
588 |
550 |
$582.33 |
| 76376 |
|
54 |
51 |
$554.84 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,836 |
1,745 |
$550.81 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
617 |
460 |
$527.03 |
| 77080 |
|
200 |
181 |
$525.88 |
| L4361 |
Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf |
45 |
39 |
$522.05 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
177 |
146 |
$505.82 |
| 85379 |
|
879 |
805 |
$500.38 |
| 95886 |
|
59 |
59 |
$490.23 |
| 86618 |
|
539 |
518 |
$479.97 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
490 |
463 |
$472.58 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
351 |
278 |
$469.19 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
64 |
28 |
$435.49 |
| 80076 |
|
172 |
166 |
$433.25 |
| 80306 |
|
1,093 |
998 |
$417.09 |
| 01480 |
|
14 |
13 |
$413.93 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,883 |
2,419 |
$366.23 |
| 82803 |
|
490 |
412 |
$350.50 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
860 |
822 |
$346.70 |
| 99220 |
|
26 |
24 |
$315.80 |
| 20610 |
|
50 |
25 |
$287.39 |
| 87205 |
|
1,070 |
1,018 |
$277.00 |
| 83970 |
|
76 |
74 |
$268.57 |
| 82077 |
|
582 |
519 |
$257.39 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,178 |
1,979 |
$255.80 |
| G0008 |
Administration of influenza virus vaccine |
1,055 |
1,021 |
$228.53 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
111 |
29 |
$219.79 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
471 |
436 |
$218.25 |
| 82565 |
|
552 |
498 |
$217.18 |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
24 |
12 |
$216.93 |
| 84100 |
|
302 |
230 |
$207.88 |
| 95911 |
|
12 |
12 |
$207.68 |
| 76536 |
|
26 |
13 |
$204.55 |
| 99217 |
|
46 |
42 |
$197.73 |
| 87468 |
|
79 |
75 |
$191.75 |
| 93226 |
|
14 |
14 |
$182.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
593 |
570 |
$172.64 |
| 86850 |
|
31 |
27 |
$163.44 |
| 97166 |
|
14 |
13 |
$160.10 |
| 86803 |
|
235 |
229 |
$158.05 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,698 |
1,605 |
$156.14 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,728 |
2,272 |
$152.40 |
| 00812 |
|
14 |
13 |
$151.05 |
| 81025 |
|
3,260 |
3,042 |
$145.93 |
| 85730 |
|
361 |
300 |
$138.40 |
| 73600 |
|
29 |
14 |
$130.94 |
| 76642 |
|
14 |
13 |
$122.28 |
| C9113 |
Injection, pantoprazole sodium, per vial |
98 |
54 |
$120.95 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
24 |
18 |
$114.46 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
261 |
229 |
$110.06 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
25 |
14 |
$108.23 |
| 82330 |
|
361 |
311 |
$105.35 |
| J2060 |
Injection, lorazepam, 2 mg |
248 |
194 |
$105.23 |
| 90686 |
|
1,176 |
1,145 |
$105.08 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
816 |
791 |
$104.65 |
| A9270 |
Non-covered item or service |
1,397 |
1,136 |
$88.37 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
810 |
785 |
$87.63 |
| 90662 |
|
50 |
47 |
$83.75 |
| 73110 |
|
17 |
15 |
$80.87 |
| 87484 |
|
79 |
75 |
$76.79 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
186 |
149 |
$63.48 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
18 |
16 |
$62.89 |
| 86901 |
|
59 |
54 |
$61.27 |
| 86900 |
|
31 |
27 |
$59.99 |
| 87478 |
|
32 |
31 |
$59.55 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
70 |
66 |
$59.44 |
| 82435 |
|
357 |
307 |
$54.97 |
| 84132 |
|
464 |
410 |
$52.01 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
214 |
207 |
$48.87 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,180 |
621 |
$48.09 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
288 |
278 |
$47.23 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
786 |
496 |
$45.81 |
| 87469 |
|
63 |
61 |
$45.20 |
| 84550 |
|
54 |
52 |
$42.84 |
| J1644 |
Injection, heparin sodium, per 1000 units |
90 |
42 |
$42.43 |
| 80143 |
|
55 |
49 |
$39.95 |
| 84520 |
|
360 |
310 |
$39.90 |
| 84295 |
|
363 |
311 |
$39.05 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
133 |
122 |
$33.01 |
| J3480 |
Injection, potassium chloride, per 2 meq |
32 |
27 |
$32.06 |
| 87081 |
|
659 |
634 |
$31.81 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,175 |
1,058 |
$29.57 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
127 |
123 |
$27.98 |
| 93244 |
|
43 |
41 |
$24.70 |
| 93227 |
|
14 |
14 |
$21.91 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
805 |
650 |
$17.43 |
| 87340 |
|
13 |
13 |
$16.82 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
65 |
63 |
$16.80 |
| 99397 |
|
32 |
12 |
$16.79 |
| 82550 |
|
31 |
26 |
$16.15 |
| 86430 |
|
30 |
25 |
$14.03 |
| 84703 |
|
57 |
54 |
$13.94 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
284 |
279 |
$12.66 |
| L3908 |
Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf |
13 |
12 |
$10.84 |
| 0124A |
|
28 |
27 |
$10.71 |
| 84702 |
|
67 |
50 |
$10.59 |
| 85014 |
|
26 |
13 |
$10.23 |
| 82947 |
|
464 |
408 |
$9.41 |
| 86706 |
|
14 |
14 |
$9.37 |
| 80179 |
|
28 |
24 |
$7.20 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
33 |
30 |
$6.20 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
13 |
13 |
$5.11 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
815 |
431 |
$4.82 |
| 87390 |
|
13 |
13 |
$3.14 |
| 84600 |
|
101 |
100 |
$2.81 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
89 |
86 |
$2.60 |
| 86702 |
|
13 |
13 |
$2.21 |
| 86701 |
|
13 |
13 |
$2.21 |
| 85018 |
|
14 |
12 |
$2.15 |
| 81002 |
|
188 |
178 |
$1.80 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
866 |
454 |
$0.66 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
211 |
181 |
$0.12 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
104 |
95 |
$0.05 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
710 |
686 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
22 |
12 |
$0.00 |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
655 |
628 |
$0.00 |
| 0002A |
|
13 |
13 |
$0.00 |
| 91300 |
|
42 |
38 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
14 |
12 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
27 |
14 |
$0.00 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
20 |
16 |
$0.00 |
| 72070 |
|
12 |
12 |
$0.00 |
| 86038 |
|
34 |
28 |
$0.00 |
| 73140 |
|
27 |
12 |
$0.00 |
| 41899 |
Unlisted procedure, dentoalveolar structures |
665 |
640 |
$0.00 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
42 |
41 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
66 |
38 |
$0.00 |
| 0012A |
|
359 |
354 |
$0.00 |
| 91301 |
|
207 |
194 |
$0.00 |
| 90656 |
|
34 |
34 |
$0.00 |
| 0011A |
|
354 |
351 |
$0.00 |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
14 |
14 |
$0.00 |
| 0001A |
|
24 |
24 |
$0.00 |
| 88142 |
|
13 |
12 |
$0.00 |